Literature DB >> 18853168

Predicting factors of postoperative relapse in T2-4N0M0 colorectal cancer patients via harvesting a minimum of 12 lymph nodes.

Hsiang-Lin Tsai1, Yung-Sung Yeh, Fang-Jung Yu, Chien-Yu Lu, Chin-Fan Chen, Chao-Wen Chen, Yu-Tang Chang, Jaw-Yuan Wang.   

Abstract

BACKGROUND AND AIM: The aim of this retrospective study was to determine which clinicopathological factors influenced the incidence of postoperative relapse and overall survival rates after radical resection of T(2-4)N(0)M(0) colorectal cancer (CRC) patients via harvesting a minimum of 12 lymph nodes.
MATERIALS AND METHODS: Between January 2001 and June 2006, a total of 342 T(2-4)N(0)M(0) CRC patients who underwent radical resection were retrospectively analyzed in Kaohsiung Medical University Hospital. Of these 342 patients, 155 were observed by harvesting a minimum of 12 lymph nodes. These 155 patients were followed up intensively, and their outcomes were investigated retrospectively.
RESULTS: Of 155 patients, 83 were men (53.5%) and 72 (46.5%) were women. The mean age was 65.5 +/- 11.1 years (range, 24-89 years). The median follow-up period was 49 months (range, 19-80 months). The present data showed invasive depth (P = 0.012), vascular invasion (P < 0.001), and perineural invasion (P = 0.009) as significantly prognostic factors for postoperative 5-year relapse rate by Kaplan-Meier analysis. Likewise, invasive depth (P = 0.013), vascular invasion (P < 0.001), and perineural invasion (P = 0.008) were significant factors for postoperative 5-year survival rate. Meanwhile, using a Cox proportional hazards analysis, depth of tumor invasion (P = 0.026) and vascular invasion (P = 0.001) were the independent predictors for postoperative relapse. Furthermore, the presence of vascular invasion was considerably correlated to the higher postoperative relapse rate and the poorer overall survival rates by survival analyses (P < 0.0001).
CONCLUSIONS: Besides the conventional depth of tumor invasion, this study highlights the potential for using vascular invasion as a means of identifying a subgroup of T(2-4)N(0)M(0) CRC patients with adequate lymph node harvest at higher risk who would potential benefit from adjuvant therapy after surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18853168     DOI: 10.1007/s00384-008-0594-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  23 in total

1.  Criteria for extramural perineural invasion as a prognostic factor in rectal cancer.

Authors:  H Ueno; K Hase; H Mochizuki
Journal:  Br J Surg       Date:  2001-07       Impact factor: 6.939

2.  THE SPREAD OF CARCINOMA OF THE RECTUM: INVASION OF LYMPHATICS, VEINS AND NERVES.

Authors:  P H Seefeld; J A Bargen
Journal:  Ann Surg       Date:  1943-07       Impact factor: 12.969

3.  Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT).

Authors:  L P Fielding; P A Arsenault; P H Chapuis; O Dent; B Gathright; J D Hardcastle; P Hermanek; J R Jass; R C Newland
Journal:  J Gastroenterol Hepatol       Date:  1991 Jul-Aug       Impact factor: 4.029

4.  Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance.

Authors:  M J Krasna; L Flancbaum; R P Cody; S Shneibaum; G Ben Ari
Journal:  Cancer       Date:  1988-03-01       Impact factor: 6.860

5.  High-risk groups of patients with Stage II colon carcinoma.

Authors:  S Merkel; A Wein; K Günther; T Papadopoulos; W Hohenberger; P Hermanek
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

6.  Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastasis.

Authors:  K Ouchi; T Sugawara; H Ono; T Fujiya; Y Kamiyama; Y Kakugawa; J Mikuni; H Tateno
Journal:  Cancer       Date:  1996-12-01       Impact factor: 6.860

7.  Prognostic value of tumor "budding" in patients with colorectal cancer.

Authors:  K Hase; C Shatney; D Johnson; M Trollope; M Vierra
Journal:  Dis Colon Rectum       Date:  1993-07       Impact factor: 4.585

8.  Follow-up of patients with colorectal cancer. A meta-analysis.

Authors:  D J Bruinvels; A M Stiggelbout; J Kievit; H C van Houwelingen; J D Habbema; C J van de Velde
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

9.  A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients.

Authors:  Frederick L Greene; Andrew K Stewart; H James Norton
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

10.  Terminology and classification of colorectal adenocarcinoma: the Australian clinico-pathological staging system.

Authors:  N C Davis; R C Newland
Journal:  Aust N Z J Surg       Date:  1983-06
View more
  9 in total

1.  Expression of IARS2 gene in colon cancer and effect of its knockdown on biological behavior of RKO cells.

Authors:  Ling Zhong; Yi Zhang; Jing-Yu Yang; Liang-Fa Xiong; Tao Shen; Ya-Lian Sa; Yi-Ming O'Yang; Si-Hui Zhao; Jia-Yong Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence.

Authors:  Tai-Yue Kuo; Edward Hsi; I-Ping Yang; Pei-Chien Tsai; Jaw-Yuan Wang; Suh-Hang Hank Juo
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

3.  Aberrant expression of LncRNA CASC2 mediated the cell viability, apoptosis and autophagy of colon cancer cells by sponging miR-19a via NF-κB signaling pathway.

Authors:  Peng Zhang; Yan Pan; Jujun Sun; Gaiyan Pan
Journal:  Int J Exp Pathol       Date:  2021-05-13       Impact factor: 2.793

4.  Prognostic factors in the patients with T2N0M0 colorectal cancer.

Authors:  Bin Xu; Lin Yu; Li-Zhong Zhao; Dong-Wang Ma
Journal:  World J Surg Oncol       Date:  2016-03-10       Impact factor: 2.754

5.  A competing risk analysis of colorectal cancer recurrence after curative surgery.

Authors:  Angela E Schellenberg; Veronika Moravan; Francis Christian
Journal:  BMC Gastroenterol       Date:  2022-03-03       Impact factor: 3.067

6.  The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse.

Authors:  I-Ping Yang; Hsiang-Lin Tsai; Ching-Wen Huang; Ming-Yii Huang; Ming-Feng Hou; Suh-Hang Hank Juo; Jaw-Yuan Wang
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

7.  Factors affecting number of lymph nodes harvested and the impact of examining a minimum of 12 lymph nodes in stage I-III colorectal cancer patients: a retrospective single institution cohort study of 1167 consecutive patients.

Authors:  Hsiang-Lin Tsai; Ching-Wen Huang; Yung-Sung Yeh; Cheng-Jen Ma; Chao-Wen Chen; Chien-Yu Lu; Ming-Yii Huang; I-Ping Yang; Jaw-Yuan Wang
Journal:  BMC Surg       Date:  2016-04-14       Impact factor: 2.102

8.  Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients.

Authors:  I-Ping Yang; Hsiang-Lin Tsai; Zhi-Feng Miao; Ching-Wen Huang; Chao-Hung Kuo; Jeng-Yih Wu; Wen-Ming Wang; Suh-Hang Hank Juo; Jaw-Yuan Wang
Journal:  J Transl Med       Date:  2016-04-29       Impact factor: 5.531

9.  A robust gene signature for the prediction of early relapse in stage I-III colon cancer.

Authors:  Weixing Dai; Yaqi Li; Shaobo Mo; Yang Feng; Long Zhang; Ye Xu; Qingguo Li; Guoxiang Cai
Journal:  Mol Oncol       Date:  2018-02-16       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.